AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Effect of Phlebotomy on Heartrate in Polycythemia Patients

Recruitingn/aAges 18 Years - anyAllLeiden University Medical Center
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Single-centre, observational within-subject design: patients that undergo phlebotomies regularly for polycythemia will be measured continuously by wearables one week before until one week after a phlebotomy, for three phlebotomies.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Patients with polycythaemia, requiring phlebotomy on a regular basis (at least every 4 months) * Subjects aged โ‰ฅ18 years * In possession of a smartphone * Life expectancy โ‰ฅ 3 months Exclusion Criteria: * Poor performance/functional status (Eastern Cooperative Oncology Group system ECOG โ‰ฅ3) * Participants with known arrhythmias or other significant cardiological conductivity disorders (Paroxysmal atrial fibrillation is allowed) * Hospitalized subjects * Subjects with a pacemaker. * Subjects with a secondary polyglobulia due to eg smoking or other pulmonary issues. * Scheduled oncological treatments or surgery during the study period.
๐Ÿ’Š

What it tests

  • phlebotomy
๐Ÿ“

Where

1 site
LUMC
Leiden, Netherlands
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy